TY - JOUR
T1 - Differential leaflet remodeling of bone marrow cell pre-seeded versus nonseeded bioresorbable transcatheter pulmonary valve replacements
AU - Fioretta, Emanuela
AU - Lintas, Valentina
AU - Mallone, Anna
AU - Motta, Sarah E.
AU - von Boehmer, Lisa
AU - Dijkman, Petra E.
AU - Cesarovic, Nikola
AU - Caliskan, Etem
AU - Rodriguez Cetina Biefer, Hector
AU - Lipiski, Miriam
AU - Sauer, Mareike
AU - Putti, Matilde
AU - Janssen, Henk M.
AU - Söntjens, Serge H.M.
AU - Smits, Anthal I.P.M.
AU - Bouten, Carlijn V.C.
AU - Emmert, M.Y.
AU - Hoerstrup, Simon P.
PY - 2020/1/1
Y1 - 2020/1/1
N2 - This study showed that bone marrow mononuclear cell pre-seeding had detrimental effects on functionality and in situ remodeling of bioresorbable bisurea-modified polycarbonate (PC-BU)-based tissue-engineered heart valves (TEHVs) used as transcatheter pulmonary valve replacement in sheep. We also showed heterogeneous valve and leaflet remodeling, which affects PC-BU TEHV safety, challenging their potential for clinical translation. We suggest that bone marrow mononuclear cell pre-seeding should not be used in combination with PC-BU TEHVs. A better understanding of cell–scaffold interaction and in situ remodeling processes is needed to improve transcatheter valve design and polymer absorption rates for a safe and clinically relevant translation of this approach.
AB - This study showed that bone marrow mononuclear cell pre-seeding had detrimental effects on functionality and in situ remodeling of bioresorbable bisurea-modified polycarbonate (PC-BU)-based tissue-engineered heart valves (TEHVs) used as transcatheter pulmonary valve replacement in sheep. We also showed heterogeneous valve and leaflet remodeling, which affects PC-BU TEHV safety, challenging their potential for clinical translation. We suggest that bone marrow mononuclear cell pre-seeding should not be used in combination with PC-BU TEHVs. A better understanding of cell–scaffold interaction and in situ remodeling processes is needed to improve transcatheter valve design and polymer absorption rates for a safe and clinically relevant translation of this approach.
KW - cardiovascular regenerative medicine
KW - endogenous tissue regeneration
KW - in situ tissue engineering
KW - supramolecular polymer
KW - tissue-engineered heart valve
UR - http://www.scopus.com/inward/record.url?scp=85077932047&partnerID=8YFLogxK
U2 - 10.1016/j.jacbts.2019.09.008
DO - 10.1016/j.jacbts.2019.09.008
M3 - Article
C2 - 32043018
VL - 5
SP - 15
EP - 31
JO - JACC: Basic to Translational Science
JF - JACC: Basic to Translational Science
SN - 2452-302X
IS - 1
ER -